1. Home
  2. ARDX vs BTZ Comparison

ARDX vs BTZ Comparison

Compare ARDX & BTZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARDX
  • BTZ
  • Stock Information
  • Founded
  • ARDX 2007
  • BTZ 2006
  • Country
  • ARDX United States
  • BTZ United States
  • Employees
  • ARDX N/A
  • BTZ N/A
  • Industry
  • ARDX Biotechnology: Pharmaceutical Preparations
  • BTZ Finance Companies
  • Sector
  • ARDX Health Care
  • BTZ Finance
  • Exchange
  • ARDX Nasdaq
  • BTZ Nasdaq
  • Market Cap
  • ARDX 882.9M
  • BTZ 997.6M
  • IPO Year
  • ARDX 2014
  • BTZ N/A
  • Fundamental
  • Price
  • ARDX $4.32
  • BTZ $10.98
  • Analyst Decision
  • ARDX Strong Buy
  • BTZ
  • Analyst Count
  • ARDX 9
  • BTZ 0
  • Target Price
  • ARDX $10.17
  • BTZ N/A
  • AVG Volume (30 Days)
  • ARDX 4.6M
  • BTZ 279.4K
  • Earning Date
  • ARDX 07-31-2025
  • BTZ 01-01-0001
  • Dividend Yield
  • ARDX N/A
  • BTZ 9.40%
  • EPS Growth
  • ARDX N/A
  • BTZ N/A
  • EPS
  • ARDX N/A
  • BTZ 1.41
  • Revenue
  • ARDX $361,706,000.00
  • BTZ N/A
  • Revenue This Year
  • ARDX $12.01
  • BTZ N/A
  • Revenue Next Year
  • ARDX $34.66
  • BTZ N/A
  • P/E Ratio
  • ARDX N/A
  • BTZ $7.57
  • Revenue Growth
  • ARDX 127.33
  • BTZ N/A
  • 52 Week Low
  • ARDX $3.21
  • BTZ $9.10
  • 52 Week High
  • ARDX $7.18
  • BTZ $11.13
  • Technical
  • Relative Strength Index (RSI)
  • ARDX 63.34
  • BTZ 73.65
  • Support Level
  • ARDX $3.49
  • BTZ $10.65
  • Resistance Level
  • ARDX $4.34
  • BTZ $10.74
  • Average True Range (ATR)
  • ARDX 0.17
  • BTZ 0.07
  • MACD
  • ARDX 0.08
  • BTZ 0.02
  • Stochastic Oscillator
  • ARDX 82.35
  • BTZ 94.59

About ARDX Ardelyx Inc.

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. It product Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

About BTZ BlackRock Credit Allocation Income Trust

Blackrock Credit Allocation Income Trust is a diversified, closed-end Trust engaged in providing investment advisory and risk management solutions. Its investment objective is to seek current income, current gains, and capital appreciation. The company invests under normal market conditions, at least 80% of its assets in credit-related securities, including, but not limited to, investment-grade corporate bonds, high-yields, bank loans, preferred securities or convertible bonds, or derivatives with economic characteristics similar to these credit-related securities.

Share on Social Networks: